Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society
Open accessThe DOI matches its Crossref record; 134 of the 141 references it cites were found in a registry or an index; 90 of the 190 sources its claims cite were checked for support.
Abstract
OBJECTIVE: To review the evidence about the impact of hypoglycemia on patients with diabetes that has become available since the past reviews of this subject by the American Diabetes Association and The Endocrine Society and to provide guidance about how this new information should be incorporated into clinical practice. PARTICIPANTS: Five members of the American Diabetes Association and five members of The Endocrine Society with expertise in different aspects of hypoglycemia were invited by the Chair, who is a member of both, to participate in a planning conference call and a 2-day meeting that was also attended by staff from both organizations. Subsequent communications took place via e-mail and phone calls. The writing group consisted of those invitees who participated in the writing of the manuscript. The workgroup meeting was supported by educational grants to the American Diabetes Association from Lilly USA, LLC and Novo Nordisk and sponsorship to the American Diabetes Association from Sanofi. The sponsors had no input into the development of or content of the report. EVIDENCE: The writing group considered data from recent clinical trials and other studies to update the prior workgroup report. Unpublished data were not used. Expert opinion was used to develop some conclusions. CONSENSUS PROCESS: Consensus was achieved by group discussion during conference calls and face-to-face meetings, as well as by iterative revisions of the written document. The document was reviewed and approved by the American Diabetes Association's Professional Practice Committee in October 2012 and approved by the Executive Committee of the Board of Directors in November 2012 and was reviewed and approved by The Endocrine Society's Clinical Affairs Core Committee in October 2012 and by Council in November 2012. CONCLUSIONS: The workgroup reconfirmed the previous definitions of hypoglycemia in diabetes, reviewed the implications of hypoglycemia on both short- and long-term outcomes, considered the implications of hypoglycemia on treatment outcomes, presented strategies to prevent hypoglycemia, and identified knowledge gaps that should be addressed by future research. In addition, tools for patients to report hypoglycemia at each visit and for clinicians to document counseling are provided.
Overview
CoChat Summary
TL;DR
This ADA/Endocrine Society workgroup report updates definitions, risks, and prevention strategies for hypoglycemia in diabetes, with a strong emphasis on avoiding severe episodes and hypoglycemia unawareness. It argues for individualized glycemic targets, better monitoring and education, and further research on outcomes, measurement, and new therapies.
Key findings
- The workgroup defines iatrogenic hypoglycemia as all episodes of abnormally low plasma glucose that expose the person to potential harm, and recommends an alert value of ≤70 mg/dL (≤3.9 mmol/L) for patients at risk; it also classifies episodes as severe, documented symptomatic, asymptomatic, probable symptomatic, or pseudo-hypoglycemia.
- Severe hypoglycemia rates reported in the paper ranged from 115 to 320 per 100 patient-years in type 1 diabetes and 35 to 70 per 100 patient-years in type 2 diabetes; because type 2 diabetes is more common, most hypoglycemia episodes occur in people with type 2 diabetes.
- In ACCORD, intensive glycemic control produced threefold higher hypoglycemia and a 20% increase in mortality; post hoc analyses in ACCORD found severe hypoglycemia had a hazard ratio of 1.41 (95% CI 1.03–1.93) for death.
- In hospitalized patients, one retrospective study found 10.5% of 31,970 general-ward admissions had at least one hypoglycemic episode (≤70 mg/dL), and severe hypoglycemia (≤50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of discharge.
Methods
- This is a workgroup report/consensus document, not an experimental study; five ADA and five Endocrine Society experts were invited, held a planning call and a 2-day meeting, and developed the manuscript through discussion and iterative revisions.
- The group reviewed recent clinical trials and other studies published since the prior reports; unpublished data were not used, and some conclusions relied on expert opinion.
- Consensus was reached by group discussion and was reviewed/approved by both organizations’ committees in October and November 2012.
Limitations
- The paper states that unpublished data were not used, and that expert opinion was used to develop some conclusions.
- The text makes evident that some evidence is observational, post hoc, or limited by small studies, so causal inference is uncertain in several areas (e.g., mortality, cognition); this is an inference from the paper’s cited evidence, not a limitation explicitly stated in one place.
- The paper explicitly notes gaps in knowledge on hypoglycemia outcomes, mechanisms, and prevention, indicating that several recommendations are based on incomplete evidence.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
59 Valid · 5 Not valid · 33 Not checked · 7 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“There is convincing evidence that formal training programs that teach patients to replace insulin “physiologically” by giving background and mealtime/correction doses of insulin can reduce the risk of severe hypoglycemia.”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > What strategies are known to prevent hypoglycemia, and what are the clinical recommendations for those at risk for hypoglycemia? > Patient education
What the sources say
- Supportedcites [100] Mühlhauser, 2002, Patient education—evaluation of a complex intervention, Diabetologia source
The Modelling section describes a structured programme teaching patients to adjust insulin doses, using NPH insulin twice daily and regular insulin before meals. The Long-term implementation section reports decreased rates of severe hypoglycaemia in patients with Type I diabetes and says several prospective studies observed that reduction. The paper supports that such programmes can reduce the risk, although not every evaluation found a reduction. (LLM, conf=0.90)
- Partly supportedcites [101] Bott, 1997, Intensified insulin therapy and the risk of severe hypoglycaemia, Diabetologia sourceExperimental — accuracy not yet measured
The Subjects and methods passage describes structured training in background and mealtime insulin dosing, with patients adjusting doses for glucose and carbohydrate intake. The Results and Discussion report fewer severe hypoglycaemic episodes after the programme, but describe the reduction as an association; they do not establish that training itself caused it. The claim’s description of this as convincing evidence that the programmes can reduce risk is therefore stronger than the paper’s finding. (LLM, conf=0.84)
- Supportedcites [102] Sämann, 2005, Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study, Diabetologia source
The Subjects and methods section describes a structured course teaching background insulin injections and meal-by-meal dose adjustments based on blood glucose and carbohydrate intake. The Abstract reports that severe hypoglycaemia fell from 0.37 to 0.14 events per patient per year after training among people with type 1 diabetes. (LLM, conf=0.92)
- Disputedcites [103] DAFNE Study Group, 2002, Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial, BMJ sourceExperimental — accuracy not yet measured
The skills course section describes training patients to adjust insulin to their meals. But the paper reports that severe hypoglycaemia remained unchanged; the Discussion says there was no significant increase, not a reduction in risk. The claimed risk reduction is therefore contrary to the reported finding. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [104] McIntyre, 2010, Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia, Med J Aust source
- Partly supportedcites [105] Hopkins, 2012, Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience, Diabetes Care sourceExperimental — accuracy not yet measured
The Results and Conclusions (pages not provided) report fewer severe hypoglycemia episodes after DAFNE, a structured education program for adults with type 1 diabetes. The paper describes adjusting insulin to carbohydrate intake, but does not specify the claimed background and mealtime/correction-dose teaching. Its evidence is also a retrospective audit based on self-reported hypoglycemia, which qualifies the claim of ‘convincing evidence.’ (LLM, conf=0.82)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12)”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion states that after an episode of hypoglycemia, the authors found elevated glycemic thresholds for neurogenic and neuroglycopenic symptoms, including in patients with IDDM in the present study. Its terminology indicates that an elevated threshold means symptoms occur at a lower plasma glucose concentration. The Results also report reduced symptom responses after antecedent hypoglycemia. (LLM, conf=0.90)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In critical care units, where the accuracy of POC meters is particularly crucial, their performance may be compromised by medications (vasopressors, acetaminophen), treatments (oxygen), and clinical states (hypotension, anemia) (17).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported? > The challenge of measuring glucose accurately
What the sources say
- Partly supportedcites [17] Klonoff, 2011, Continuous glucose monitoring: an Endocrine Society Clinical Practice Guideline, J Clin Endocrinol Metab sourceExperimental — accuracy not yet measured
Section 1.1 Evidence says supplemental oxygen can cause falsely low readings with glucose-oxidase meters and identifies acetaminophen, pressor use, and hypotension as potential concerns for POC testing in critically ill patients. It also reports an accuracy discrepancy among patients with hypotension or pressor treatment. The cited passages do not address anemia as a cause of compromised meter performance. (LLM, conf=0.88)
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“A single threshold value for plasma glucose concentration that defines hypoglycemia in diabetes cannot be assigned because glycemic thresholds for symptoms of hypoglycemia (among other responses) shift to lower plasma glucose concentrations after recent antecedent hypoglycemia (9–12) and to higher plasma glucose concentrations in patients with poorly controlled diabetes and infrequent hypoglycemia”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Not checked — no full text of the sourcecites [9] Amiel, 1988, Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release, Diabetes source
- Supportedcites [10] Dagogo-Jack, 1993, Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia, J Clin Invest source
The Discussion (p. 823) reports that antecedent hypoglycemia changes the glycemic threshold for symptoms in patients with insulin-dependent diabetes. The Discussion also reports symptoms at higher plasma glucose concentrations in patients with poorly or moderately controlled diabetes. Together, these findings support the claim that no single symptom-based plasma glucose threshold applies across these circumstances. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [11] Davis, 1997, Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans, Diabetes source
- Not checked — no full text of the sourcecites [12] Heller, 1991, Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans, Diabetes source
- Not checked — no full text of the sourcecites [13] Boyle, 1988, Plasma glucose concentrations at the onset of hypoglycemic symptoms in patients with poorly controlled diabetes and in nondiabetics, N Engl J Med source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Hypoglycemia puts patients at risk for injury and death.”
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
“There is no doubt that hypoglycemia can be fatal (26).”
§ Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society > How should hypoglycemia in diabetes be defined and reported?
What the sources say
- Supportedcites [26] Cryer, 2011, Death during intensive glycemic therapy of diabetes: mechanisms and implications, Am J Med source
In the main text (page unavailable), Cryer states that iatrogenic hypoglycemia causes recurrent morbidity in people with diabetes and is sometimes fatal. This supports the broad claim that hypoglycemia puts these patients at risk of harm and death. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § What are the implications of hypoglycemia on both short- and long-term outcomes in people with diabetes? · plain
76 more claims · 43 with their cited sources checked
Create a free account to see all 104 claims and to verify the 4 references still open.
- It may state two separate claims as one. 21
- Probably not a substantial claim. 2
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Postprandial hyperglycemia and resultant compensatory hyperinsulinemia from high dietary glycemic load can lower plasma glucose to concentrations that compromise brain glucose, w70 mg/dL (3.8 mmol/L) (36), triggering the secretion of autonomic counterregulatory hormones such as adrenaline, cortisol, glucagon, and growth hormone (37).”
From High glycemic index diet as a risk factor for depression: analyses from the Women’s Health Initiative (2015) · cites this paper as [36]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Risks for hypoglycemia, particularly level 3 hypoglycemia, include longer duration of diabetes, older age, history of recent level 3 hypoglycemia, alcohol ingestion, exercise, lower education levels, lower household incomes (41), chronic kidney disease, and IAH (103-105).”
From The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) (2021) · cites this paper as [103]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Recurrent hypoglycaemia results in an increased likelihood of hypoglycaemia unawareness and subsequent severe hypoglycaemic events, since recurrent hypoglycaemia reduces the glucose concentration that triggers the counter-regulatory responses to return to euglycaemia.106”
From Type 1 diabetes (2018) · cites this paper as [106]
The cited source says what the claim attributes to it.
In the citing paper
“Hypoglycemia is a frequent and dangerous complication of diabetes (1), causing changes in physiological parameters (2,3).”
From Noninvasive Hypoglycemia Detection in People With Diabetes Using Smartwatch Data (2023) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Individualized glucose targets, patient education, nutrition intervention (e.g., bedtime snack to prevent overnight hypoglycemia when specifically needed to treat low blood glucose), physical activity management, medication adjustment, glucose monitoring, and routine clinical surveillance may improve patient outcomes (94).”
From 6. Glycemic Targets: Standards of Care in Diabetes—2023 (2023) · cites this paper as [94]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
A note, not an issue: for example, a cited work that was retracted only after this paper was published, which its authors could not have known.
In the paper
“Deakin T McShane CE Cade JE Williams RD Group based training for self-management strategies in people with type 2 diabetes mellitus. Cochrane Database Syst Rev 2005; 2: CD003417 15846663”
Cited work 10.1002/14651858.cd003417.pub2 · retracted 2015-06-30 · notice 10.1002/14651858.cd003417.pub3 · this paper published 2013-04-13
Citations
Cites
1 retracted
Group based training for self-management strategies in people with type 2 diabetes mellitus
Deakin, T. A., McShane, C. E., Cade, J. E., & Williams, R. (2005) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003417.pub2 · Cited by 862
RetractedIntensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Hyperglycemia and adverse pregnancy outcomes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707943 · Cited by 5,563
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762 · cited 1×
“In VADT, a recent severe hypoglycemic event was the strongest independent predictor of death at 90 days (3).”
BackgroundInzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetologia · doi:10.1007/s00125-012-2534-0 · Cited by 3,919 · cited 2×
“event of troublesome hypoglycemia (96).”
BackgroundIntensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
Inzucchi, S. E., Bergenstal, R. M., Buse, J. B., Diamant, M., Ferrannini, E., Nauck, M., Peters, A. L., Tsapas, A., Wender, R., & Matthews, D. R. (2012) · Diabetes Care · doi:10.2337/dc12-0413 · Cited by 3,207
Intensive insulin therapy and pentastarch resuscitation in severe sepsis
Brunkhorst, F. M., Engel, C., Bloos, F., Meier-Hellmann, A., Ragaller, M., Weiler, N., Moerer, O., Gruendling, M., Oppert, M., Grond, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa070716 · Cited by 2,921
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2012.03923.x · Cited by 2,578
Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Effectiveness of Self-Management Training in Type 2 Diabetes
Norris, S. L., Engelgau, M. M., & Venkat Narayan, K. M. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.561 · Cited by 1,846
Nathan, D. M., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2112 · Cited by 1,832
Capes, S. E., Hunt, D., Malmberg, K., Pathak, P., & Gerstein, H. C. (2001) · Stroke · doi:10.1161/hs1001.096194 · Cited by 1,824
Self-Management Education for Adults With Type 2 Diabetes
Norris, S. L., Lau, J., Smith, S. J., Schmid, C. H., & Engelgau, M. M. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1159 · Cited by 1,750
Severe hypoglycemia and risks of vascular events and death
Zoungas, S., Patel, A., Chalmers, J., de Galan, B. E., Li, Q., Billot, L., Woodward, M., Ninomiya, T., Neal, B., MacMahon, S., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003795 · Cited by 1,471 · cited 1×
“In ADVANCE, where rates of hypoglycemia were low, a similar pattern was found (47).”
ResultSelf-citationEvaluating clinical accuracy of systems for self-monitoring of blood glucose
Clarke, W. L., Cox, D., Gonder-Frederick, L. A., Carter, W., & Pohl, S. L. (1987) · Diabetes Care · doi:10.2337/diacare.10.5.622 · Cited by 1,435 · cited 1×
“However, the accuracy of CGMs in the hypoglycemic range is poor as demonstrated by error grid analysis (19,20).”
BackgroundEconomic costs of diabetes in the U.S. in 2007
American Diabetes Association (2008) · Diabetes Care · doi:10.2337/dc08-9017 · Cited by 1,323
Care of Children and Adolescents With Type 1 Diabetes
Silverstein, J., Klingensmith, G., Copeland, K., Plotnick, L., Kaufman, F., Laffel, L., Deeb, L., Grey, M., Anderson, B., Holzmeister, L. A., et al. (2005) · Diabetes Care · doi:10.2337/diacare.28.1.186 · Cited by 1,312
Cryer, P. E., Axelrod, L., Grossman, A. B., Heller, S. R., Montori, V. M., Seaquist, E. R., & Service, F. J. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-1410 · Cited by 1,277
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
McCowen, K. C., Malhotra, A., & Bistrian, B. R. (2001) · Critical Care Clinics · doi:10.1016/s0749-0704(05)70154-8 · Cited by 1,170
Defining and Reporting Hypoglycemia in Diabetes
American Diabetes Association Workgroup on Hypoglycemia (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1245 · Cited by 1,146
Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus
Whitmer, R. A. (2009) · JAMA · doi:10.1001/jama.2009.460 · Cited by 1,128 · cited 1×
“In a large population study, hypoglycemic episodes that required hospitalization or a visit to the emergency department between 1980 and 2002 were associated with approximately double the risk of incident dementia after 2003 (6).”
BackgroundGriesdale, D. E. G., de Souza, R. J., van Dam, R. M., Heyland, D. K., Cook, D. J., Malhotra, A., Dhaliwal, R., Henderson, W. R., Chittock, D. R., Finfer, S., et al. (2009) · Canadian Medical Association Journal · doi:10.1503/cmaj.090206 · Cited by 1,096
Gerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Bonds, D. E., Miller, M. E., Bergenstal, R. M., Buse, J. B., Byington, R. P., Cutler, J. A., Dudl, R. J., Ismail-Beigi, F., Kimel, A. R., Hoogwerf, B., et al. (2010) · BMJ · doi:10.1136/bmj.b4909 · Cited by 933 · cited 1×
“In the opinion of the blinded adjudication committee assigned to investigate mortality in ACCORD, hypoglycemia was judged to have a definite role in only one death, a probable role in three deaths, and a possible role in 38 deaths (46), which represents a role in less than 10% of the deaths recorded in the study popul…”
BackgroundSelf-citation(2002) · BMJ · doi:10.1136/bmj.325.7367.746 · Cited by 916 · cited 1×
“These programs have been successfully delivered in other settings (103,104) with comparable reductions in hypoglycemic risk (105).”
BackgroundRisk of hypoglycaemia in types 1 and 2 diabetes: Effects of treatment modalities and their duration
UK Hypoglycaemia Study Group (2007) · Diabetologia · doi:10.1007/s00125-007-0599-y · Cited by 825 · cited 4×
“Event rates for severe hypoglycemia for patients with type 1 diabetes range from 115 (24) to 320 (23) per 100 patient-years.”
BackgroundInfluentialEpidemiology of severe hypoglycemia in the Diabetes Control and Complications Trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90605-w · Cited by 807
Epidemiology of severe hypoglycemia in the diabetes control and complications trial
(1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)80085-z · Cited by 807
Inzucchi, S., Bergenstal, R., Buse, J., Diamant, M., Ferrannini, E., Nauck, M., Peters, A., Tsapas, A., Wender, R., & Matthews, D. (2013) · Diabetes Care · doi:10.2337/dc13-er02 · Cited by 805 · cited 2×
“For patients with type 2 diabetes, sulfonylureas are the oral agents that pose the greatest risk for iatrogenic hypoglycemia and substitution with other classes of oral agents or even glucagon-like peptide 1 analogs should be considered in the event of troublesome hypoglycemia (96).”
BackgroundEconomic Costs of Diabetes in the U.S. in 2007
Leahy, J. L. (2008) · Yearbook of Endocrinology · doi:10.1016/s0084-3741(08)79219-9 · Cited by 781
The barrier of hypoglycemia in diabetes
Cryer, P. E. (2008) · Diabetes · doi:10.2337/db08-1084 · Cited by 725 · cited 2×
“However, because type 2 diabetes is much more prevalent than type 1 diabetes, most episodes of hypoglycemia, including severe hypoglycemia, occur in people with type 2 diabetes (25).”
BackgroundSelf-citationAmiel, S. A., Beveridge, S., Bradley, C., Gianfrancesco, C., Heller, S. R., James, P., McKeown, N., Newton, D. F., Newton, L. D., Oliver, L., et al. (2002) · Deakin Research Online (Deakin University) · Cited by 723
Self-citationSevere hypoglycemia in critically ill patients: risk factors and outcomes
Krinsley, J. S., & Grover, A. (2007) · Critical Care Medicine · doi:10.1097/01.ccm.0000282073.98414.4b · Cited by 671 · cited 2×
“The risk factors for inpatient hypoglycemia include older age, presence of comorbidities, diabetes, increasing number of antidiabetic agents, tight glycemic control, septic shock, renal insufficiency, mechanical ventilation, and severity of illness (75,76).”
BackgroundLong-term effect of diabetes and its treatment on cognitive function
(2007) · New England Journal of Medicine · doi:10.1056/nejmoa066397 · Cited by 646
Parkes, J. L., Slatin, S. L., Pardo, S., & Ginsberg, B. H. (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1143 · Cited by 620 · cited 1×
“However, the accuracy of CGMs in the hypoglycemic range is poor as demonstrated by error grid analysis (19,20).”
BackgroundLauner, L. J., Miller, M. E., Williamson, J. D., Lazar, R. M., Gerstein, H. C., Murray, A. M., Sullivan, M., Horowitz, K. R., Ding, J., Marcovina, S., et al. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70188-0 · Cited by 574 · cited 1×
“In the ACCORD MIND (Memory IN Diabetes) study, in which cognitive function was assessed longitudinally, no difference was noted in the rate at which cognitive performance declined over time in subjects randomly assigned to the intensive versus the standard glucose arms despite the fact that they experienced three time…”
BackgroundHeller, S. R., & Cryer, P. E. (1991) · Diabetes · doi:10.2337/diab.40.2.223 · Cited by 531
Self-citationStrachan, M. W. J., Deary, I. J., Ewing, F. M. E., & Frier, B. M. (1997) · Diabetes Care · doi:10.2337/diacare.20.3.438 · Cited by 529 · cited 1×
“Tominimize the risk of hypoglycemia in the elderly, careful education regarding the symptoms and treatment of hypoglycemia, with regular reinforcement, is extremely important because of the recognized gaps in the knowledge base of these individuals (59).”
BackgroundDonnelly, L. A., Morris, A. D., Frier, B. M., Ellis, J. D., Donnan, P. T., Durrant, R., Band, M. M., Reekie, G., & Leese, G. P. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01501.x · Cited by 511 · cited 3×
“Event rates for severe hypoglycemia for patients with type 1 diabetes range from 115 (24) to 320 (23) per 100 patient-years.”
BackgroundHyperglycemia and Adverse Pregnancy Outcomes: The HAPO Study Cooperative Research Group
(2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e318187b7a2 · Cited by 488
Dagogo-Jack, S. E., Craft, S., & Cryer, P. E. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116302 · Cited by 471 · cited 1×
“In published studies, this has required frequent (almost daily) contact between clinician and patient, and adjustments to caloric intake and insulin regimen based on blood glucose values (10,119,120).”
BackgroundSelf-citationIncidence and risk factors for serious hypoglycemia in older persons using insulin or sulfonylureas
Shorr, R. I. (1997) · Archives of Internal Medicine · doi:10.1001/archinte.1997.00440360095010 · Cited by 459 · cited 1×
“The most significant predictors of this condition are advanced age, recent hospitalization, and polypharmacy, as shown in a study of Tennessee Medicare patients (51).”
BackgroundHypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward
Turchin, A., Matheny, M. E., Shubina, M., Scanlon, J. V., Greenwood, B., & Pendergrass, M. L. (2009) · Diabetes Care · doi:10.2337/dc08-2127 · Cited by 453 · cited 1×
“With regard to impact, a retrospective analysis of 4,368 admissions involving 2,582 diabetic patients admitted to the general ward indicated that severe hypoglycemia (#50 mg/dL) was associated with increased length of stay and greater odds of inpatient death and death within 1 year of hospital discharge (77).”
BackgroundRestoration of hypoglycaemia awareness in patients with long-duration insulin-dependent diabetes.
Cranston, I., Lomas, J., Amiel, S. A., Maran, A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91336-6 · Cited by 430 · cited 2×
“5%) in HbAlc values (33), but others have reported no loss of glycemic control (32,34).”
BackgroundFanelli, C. G., Epifano, L., Rambotti, A. M., Pampanelli, S., Di Vincenzo, A., Modarelli, F., Lepore, M., Annibale, B., Ciofetta, M., Bottini, P., et al. (1993) · Diabetes · doi:10.2337/diab.42.11.1683 · Cited by 398 · cited 2×
“In published studies, this has required frequent (almost daily) contact between clinician and patient, and adjustments to caloric intake and insulin regimen based on blood glucose values (10,119,120).”
BackgroundEffect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.
Amiel, S. A., Sherwin, R. S., Simonson, D. C., & Tamborlane, W. V. (1988) · Diabetes · doi:10.2337/diab.37.7.901 · Cited by 393 · cited 2×
“Although this alert value has been debated (9,13,14), a plasma concentration of #70 mg/dL (#3.”
BackgroundWhite, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391 · cited 1×
“The development of HAAF is associated with a 25-fold (35) or greater (36) increased risk of severe hypoglycemia during intensive glycemic therapy.”
BackgroundSelf-citationLong-term mortality in a nationwide cohort of childhood-onset type 1 diabetic patients in Norway
Skrivarhaug, T., Bangstad, H.-J., Stene, L. C., Sandvik, L., Hanssen, K. F., & Joner, G. (2006) · Diabetologia · doi:10.1007/s00125-005-0082-6 · Cited by 390
Poor Cognitive Function and Risk of Severe Hypoglycemia in Type 2 Diabetes
Punthakee, Z., Miller, M. E., Launer, L. J., Williamson, J. D., Lazar, R. M., Cukierman-Yaffee, T., Seaquist, E. R., Ismail-Beigi, F., Sullivan, M. D., Lovato, L. C., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1855 · Cited by 337
Self-citationHypoglycemia-associated autonomic failure in advanced type 2 diabetes.
Segel, S. A., Paramore, D. S., & Cryer, P. E. (2002) · Diabetes · doi:10.2337/diabetes.51.3.724 · Cited by 337 · cited 1×
“diabetes as is often seen in the elderly patient, the glucagon response to hypoglycemia is virtually absent (55).”
BackgroundSelf-citationReversal of hypoglycemia unawareness, but not defective glucose counterregulation, in IDDM.
Dagogo-Jack, S., Rattarasarn, C., & Cryer, P. E. (1994) · Diabetes · doi:10.2337/diab.43.12.1426 · Cited by 328 · cited 4×
“A self-reported history of impaired or absent perception of autonomic symptoms during hypoglycemia correlates strongly with laboratory confirmation of hypoglycemia unawareness (33,121,124,125).”
BackgroundInfluentialSelf-citationAmiel, S. A., Tamborlane, W. V., Simonson, D. C., & Sherwin, R. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162205 · Cited by 309 · cited 1×
“In published studies, this has required frequent (almost daily) contact between clinician and patient, and adjustments to caloric intake and insulin regimen based on blood glucose values (10,119,120).”
BackgroundSinclair, A. J., Paolisso, G., Castro, M., Bourdel-Marchasson, I., Gadsby, R., & Rodriguez Mañas, L. (2011) · Diabetes & Metabolism · doi:10.1016/s1262-3636(11)70962-4 · Cited by 298
Physical activity/exercise and diabetes mellitus
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.2007.s73 · Cited by 271
Hopkins, D., Lawrence, I., Mansell, P., Thompson, G., Amiel, S., Campbell, M., & Heller, S. (2012) · Diabetes Care · doi:10.2337/dc11-1579 · Cited by 265 · cited 1×
“These programs have been successfully delivered in other settings (103,104) with comparable reductions in hypoglycemic risk (105).”
BackgroundSelf-citationBoyle, P. J., Schwartz, N. S., Shah, S. D., Clutter, W. E., & Cryer, P. E. (1988) · New England Journal of Medicine · doi:10.1056/nejm198806093182302 · Cited by 258 · cited 3×
“Although this alert value has been debated (9,13,14), a plasma concentration of #70 mg/dL (#3.”
BackgroundSelf-citation(1991) · PubMed · Cited by 245
Perantie, D. C., Lim, A., Wu, J., Weaver, P., Warren, S. L., Sadler, M., White, N. H., & Hershey, T. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2007.00274.x · Cited by 237 · cited 2×
“Since then, new evidence has become available that links hypoglycemia with adverse outcomes in older patients with type 2 diabetes (3–6) and in children with type 1 diabetes (7,8).”
BackgroundDiabetes-related morbidity and mortality in a national sample of U.S. elders
Bertoni, A. G., Krop, J. S., Anderson, G. F., & Brancati, F. L. (2002) · Diabetes Care · doi:10.2337/diacare.25.3.471 · Cited by 230
Sämann, A., Mühlhauser, I., Bender, R., Kloos, C., & Müller, U. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1905-1 · Cited by 226 · cited 1×
“The Insulin Treatment and Training programs developed by M€ uhlhauser and Berger (100) have reported improved glycemic control comparable with DCCT while reducing the rates of severe hypoglycemia (101,102).”
BackgroundCox, D. J., Gonder-Frederick, L. A., Kovatchev, B. P., Julian, D. M., & Clarke, W. L. (2000) · Diabetes Care · doi:10.2337/diacare.23.2.163 · Cited by 226
Tanenberg, R. J., Newton, C. A., & Drake, A. J. (2010) · Endocrine Practice · doi:10.4158/ep09260.cr · Cited by 225 · cited 1×
“A temporal relationship between extremely low subcutaneous glucose concentrations and death in a patient with type 1 diabetes who was wearing a CGM device and was found dead in bed has been reported (31).”
BackgroundImpact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes
Davis, R. E., Morrissey, M., Peters, J. R., Wittrup-Jensen, K., Kennedy-Martin, T., & Currie, C. J. (2005) · Current Medical Research and Opinion · doi:10.1185/030079905x61929 · Cited by 218 · cited 1×
“This difficulty may carry over to their work life, where hypoglycemia has been linked to reduced productivity (88).”
BackgroundPatterson, C. C., Dahlquist, G., Harjutsalo, V., Joner, G., Feltbower, R. G., Svensson, J., Schober, E., Gyürüs, E., Castell, C., Urbonaité, B., et al. (2007) · Diabetologia · doi:10.1007/s00125-007-0824-8 · Cited by 213 · cited 1×
“In addition to case reports of hypoglycemic deaths in patients with type 1 and type 2 diabetes, four recent reports of mortality rates in series of patients indicate that 4% (27), 6% (28), 7% (29), and 10% (30) of deaths of patients with type 1 diabetes were caused by hypoglycemia.”
BackgroundFanelli, C., Pampanelli, S., Epifano, L., Rambotti, A. M., Di Vincenzo, A., Modarelli, F., Ciofetta, M., Lepore, M., Annibale, B., Torlone, E., et al. (1994) · Diabetologia · doi:10.1007/bf00399801 · Cited by 212 · cited 2×
“Indeed, HAAF has been shown to be maintained by recurrent iatrogenic hypoglycemia (33,34).”
BackgroundContinuous glucose monitoring: an Endocrine Society Clinical Practice Guideline
Klonoff, D. C., Buckingham, B., Christiansen, J. S., Montori, V. M., Tamborlane, W. V., Vigersky, R. A., & Wolpert, H. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2756 · Cited by 211
Self-citationBenefits and Risks of Tight Glucose Control in Critically Ill Adults: A Meta-analysis
Wiener, R. S., Wiener, D. C., & Larson, R. J. (2008) · JAMA · doi:10.1001/jama.300.8.933 · Cited by 200
System Accuracy Evaluation of 27 Blood Glucose Monitoring Systems According to DIN EN ISO 15197
Freckmann, G., Baumstark, A., Jendrike, N., Zschornack, E., Kocher, S., Tshiananga, J., Heister, F., & Haug, C. (2010) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2009.0128 · Cited by 195 · cited 1×
“(16) found that only 15 of 27 meters on the market in Europe several years ago met the current analytical standards of 15 mg/dL in the hypoglycemia range, 2 of 27 met 10 mg/dL, and none were capable of measuring 5 mg/dL.”
BackgroundAssessment and management of hypoglycemia in children and adolescents with diabetes
Clarke, W., Jones, T., Rewers, A., Dunger, D., & Klingensmith, G. J. (2008) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2008.00405.x · Cited by 189
Effects of differing antecedent hypoglycemia on subsequent counterregulation in normal humans
Davis, S. N., Shavers, C., Mosqueda-Garcia, R., & Costa, F. (1997) · Diabetes · doi:10.2337/diab.46.8.1328 · Cited by 183 · cited 1×
“Given the limited accuracy of the monitoring devices, it approximates the lower limit of the normal postabsorptive plasma glucose concentration (15), the glycemic thresholds for activation of glucose counterregulatory systems in nondiabetic individuals (15), and the upper limit of plasma glucose level reported to redu…”
BackgroundFeltbower, R. G., Bodansky, H. J., Patterson, C. C., Parslow, R. C., Stephenson, C. R., Reynolds, C., & McKinney, P. A. (2008) · Diabetes Care · doi:10.2337/dc07-2029 · Cited by 183 · cited 1×
“In addition to case reports of hypoglycemic deaths in patients with type 1 and type 2 diabetes, four recent reports of mortality rates in series of patients indicate that 4% (27), 6% (28), 7% (29), and 10% (30) of deaths of patients with type 1 diabetes were caused by hypoglycemia.”
BackgroundIntensified insulin therapy and the risk of severe hypoglycaemia
Bott, S., Bott, U., Berger, M., & Mühlhauser, I. (1997) · Diabetologia · doi:10.1007/s001250050769 · Cited by 180 · cited 1×
“The Insulin Treatment and Training programs developed by M€ uhlhauser and Berger (100) have reported improved glycemic control comparable with DCCT while reducing the rates of severe hypoglycemia (101,102).”
BackgroundImpact of diabetes on physical function in older people
Sinclair, A. J., Conroy, S. P., & Bayer, A. J. (2008) · Diabetes Care · doi:10.2337/dc07-1784 · Cited by 179
Hypoglycemia-associated mortality is not drug-associated but linked to comorbidities
Boucai, L., Southern, W. N., & Zonszein, J. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.07.011 · Cited by 175 · cited 2×
“The risk factors for inpatient hypoglycemia include older age, presence of comorbidities, diabetes, increasing number of antidiabetic agents, tight glycemic control, septic shock, renal insufficiency, mechanical ventilation, and severity of illness (75,76).”
BackgroundInsulin Pump Therapy With Automated Insulin Suspension in Response to Hypoglycemia
Choudhary, P., Shin, J., Wang, Y., Evans, M. L., Hammond, P. J., Kerr, D., Shaw, J. A. M., Pickup, J. C., & Amiel, S. A. (2011) · Diabetes Care · doi:10.2337/dc10-2411 · Cited by 175
Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women
Yogev, Y., Ben-Haroush, A., Chen, R., Rosenn, B., Hod, M., & Langer, O. (2004) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2004.06.059 · Cited by 168 · cited 1×
“Normal blood glucose levels during pregnancy are 20% lower than in nonpregnant women (79),making the definition and detection of hypoglycemia more challenging.”
BackgroundCounterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes
Meneilly, G. S., Cheung, E., & Tuokko, H. (1994) · Diabetes · doi:10.2337/diab.43.3.403 · Cited by 167 · cited 1×
“Age-related impairment in counterregulatory hormone responses has been described in elderly patients with diabetes, especially with respect to glucagon and growth hormone (53).”
BackgroundCounterregulatory hormone responses to hypoglycemia in the elderly patient with diabetes
Meneilly, G. S., Cheung, E., & Tuokko, H. (1994) · Diabetes · doi:10.2337/diabetes.43.3.403 · Cited by 167
Linkeschova, R., Raoul, M., Bott, U., Berger, M., & Spraul, M. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00713.x · Cited by 165 · cited 1×
“Continuous subcutaneous insulin infusion offers great flexibility for adjusting the doses and administration pattern of insulin to counteract iatrogenic hypoglycemia (115).”
BackgroundBarendse, S., Singh, H., Frier, B. M., & Speight, J. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2011.03416.x · Cited by 161 · cited 1×
“Impact of hypoglycemia on quality of life and activities of daily living Hypoglycemia and the fear of hypoglycemia have a significant impact on qualityof-life measures in patients with both type 1 and type 2 diabetes (83).”
BackgroundBruce, D. G., Casey, G. P., Grange, V., Clarnette, R. C., Almeida, O. P., Foster, J. K., Ives, F. J., & Davis, T. M. E. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(03)00084-6 · Cited by 145 · cited 1×
“Older adults with diabetes are at much higher risk for the geriatric syndrome, which includes falls, incontinence, frailty, cognitive impairment, and depressive symptoms (57).”
BackgroundDeath during intensive glycemic therapy of diabetes: mechanisms and implications
Cryer, P. E. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.08.008 · Cited by 137 · cited 3×
“Although profound and prolonged hypoglycemia can cause brain death, most episodes of fatal hypoglycemia are probably the result of other mechanisms, such as ventricular arrhythmias (26).”
BackgroundInfluentialSelf-citationAssessment and management of hypoglycemia in children and adolescents with diabetes
Clarke, W., Jones, T., Rewers, A., Dunger, D., & Klingensmith, G. J. (2009) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2009.00583.x · Cited by 135
Prediction of Severe Hypoglycemia
Cox, D. J., Gonder-Frederick, L., Ritterband, L., Clarke, W., & Kovatchev, B. P. (2007) · Diabetes Care · doi:10.2337/dc06-1386 · Cited by 129
A reliable and reproducible test for adequate glucose counterregulation in type I diabetes mellitus.
Bolli, G. B., Feo, P. D., Cosmo, S. D., Perriello, G., Ventura, M. M., Benedetti, M. M., Santeusanio, F., Gerich, J. E., & Brunetti, P. (1984) · Diabetes · doi:10.2337/diab.33.8.732 · Cited by 124 · cited 1×
“The development of HAAF is associated with a 25-fold (35) or greater (36) increased risk of severe hypoglycemia during intensive glycemic therapy.”
BackgroundChipkin, S. R., Klugh, S. A., & Chasan-Taber, L. (2001) · Cardiology Clinics · doi:10.1016/s0733-8651(05)70231-9 · Cited by 123
Driving decrements in type I diabetes during moderate hypoglycemia
Cox, D. J., Gonder-Frederick, L., & Clarke, W. (1993) · Diabetes · doi:10.2337/diab.42.2.239 · Cited by 123
Impact of diabetes mellitus on cardiac surgery outcome
Bucerius, J., Gummert, J., Walther, T., Doll, N., Falk, V., Onnasch, J., Barten, M., & Mohr, F. (2004) · The Thoracic and Cardiovascular Surgeon · doi:10.1055/s-2003-37280 · Cited by 120
Strachan, M. W., Deary, I. J., Ewing, F. M., & Frier, B. M. (2000) · Diabetes Care · doi:10.2337/diacare.23.3.305 · Cited by 113 · cited 1×
“Patients with recurrent hypoglycemia have been found to have chronic mood disorders including depression and anxiety (85,86), although it is hard to establish cause and effect between hypoglycemia and mood changes.”
BackgroundSmith, C. B., Choudhary, P., Pernet, A., Hopkins, D., & Amiel, S. A. (2009) · Diabetes Care · doi:10.2337/dc08-2259 · Cited by 106
Hannonen, R., Tupola, S., Ahonen, T., & Riikonen, R. (2003) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2003.tb00341.x · Cited by 106 · cited 1×
“Ongoing maturation of the central nervous system puts these children at greater risk for cognitive deficits as a consequence of hypoglycemia (44).”
BackgroundProspectively Determined Impact of Type 1 Diabetes on Brain Volume During Development
Perantie, D. C., Koller, J. M., Weaver, P. M., Lugar, H. M., Black, K. J., White, N. H., & Hershey, T. (2011) · Diabetes · doi:10.2337/db11-0589 · Cited by 104 · cited 1×
“Since then, new evidence has become available that links hypoglycemia with adverse outcomes in older patients with type 2 diabetes (3–6) and in children with type 1 diabetes (7,8).”
BackgroundPuente, E. C., Silverstein, J., Bree, A. J., Musikantow, D. R., Wozniak, D. F., Maloney, S., Daphna-Iken, D., & Fisher, S. J. (2010) · Diabetes · doi:10.2337/db09-1495 · Cited by 103 · cited 1×
“Rats subjected to recurrent moderate hypoglycemia had less brain cell death (40) and less mortality (41) during or following marked hypoglycemia than those not subjected to recurrent hypoglycemia.”
BackgroundJaferi, A., Nowak, N., & Bhatnagar, S. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00014-3 · Cited by 102 · cited 1×
“The HAAF habituation of the sympathoadrenal response to recurrent hypoglycemic stress in humans (38) may be analogous to the phenomenon of habituation of the hypothalamic-pituitary-adrenocortical response to recurrent restraint stress in rats (39).”
BackgroundPatient education—evaluation of a complex intervention
I., M., & M., B. (2002) · Diabetologia · doi:10.1007/s00125-002-0987-2 · Cited by 102
Hypoglycaemia during pregnancy in women with Type 1 diabetes
Ringholm, L., Pedersen‐Bjergaard, U., Thorsteinsson, B., Damm, P., & Mathiesen, E. R. (2012) · Diabetic Medicine · doi:10.1111/j.1464-5491.2012.03604.x · Cited by 101 · cited 1×
“For women with type 1 diabetes, severe hypoglycemia occurs 3–5 times more frequently in the first trimester and at a lower rate in the third trimester when compared with the incidence in the year preceding the pregnancy (80).”
BackgroundRestoration of hypoglycemia awareness after islet transplantation
Leitão, C. B., Tharavanij, T., Cure, P., Pileggi, A., Baidal, D. A., Ricordi, C., & Alejandro, R. (2008) · Diabetes Care · doi:10.2337/dc08-0741 · Cited by 101
Fritsche, A., Stefan, N., Häring, H., Gerich, J., & Stumvoll, M. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-9_part_1-200105010-00009 · Cited by 98 · cited 1×
“In such a program, patients and their relatives are trained to recognize subtle cues and early neuroglycopenic indicators of evolving hypoglycemia and respond to them before the occurrence of disabling hypoglycemia (106,107).”
BackgroundGlucose meter performance criteria for tight glycemic control estimated by simulation modeling
Karon, B. S., Boyd, J. C., & Klee, G. G. (2010) · Clinical Chemistry · doi:10.1373/clinchem.2010.145367 · Cited by 94 · cited 1×
“(18) translated these measurement errors into potential insulin-dosing errors using simulation modeling and found that if there were a total measurement error of 20%, 1- and 2-step errors in insulin dose would occur 45% and 6% of the time, respectively, in a tight glycemic control protocol.”
BackgroundNocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments
Raju, B., Arbelaez, A. M., Breckenridge, S. M., & Cryer, P. E. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2798 · Cited by 93
Self-citationAttenuation of Counterregulatory Responses to Recurrent Hypoglycemia by Active Thalamic Inhibition
Arbelaez, A. M., Powers, W. J., Videen, T. O., Price, J. L., & Cryer, P. E. (2008) · Diabetes · doi:10.2337/db07-1329 · Cited by 92 · cited 1×
“The HAAF habituation of the sympathoadrenal response to recurrent hypoglycemic stress in humans (38) may be analogous to the phenomenon of habituation of the hypothalamic-pituitary-adrenocortical response to recurrent restraint stress in rats (39).”
BackgroundSelf-citationBreastfeeding and the basal insulin requirement in type 1 diabetic women
Riviello, C., Mello, G., & Jovanovic, L. G. (2009) · Endocrine Practice · doi:10.4158/ep.15.3.187 · Cited by 87 · cited 1×
“Breastfeeding may also be a risk factor for hypoglycemia in women with insulin-treated diabetes (82).”
BackgroundKalergis, M., Schiffrin, A., Gougeon, R., Jones, P. J. H., & Yale, J.-F. (2003) · Diabetes Care · doi:10.2337/diacare.26.1.9 · Cited by 82
Well-being, cerebral function, and physical fatigue after nocturnal hypoglycemia in IDDM
King, P., Kong, M.-F., Parkin, H., Macdonald, I. A., & Tattersall, R. B. (1998) · Diabetes Care · doi:10.2337/diacare.21.3.341 · Cited by 82 · cited 1×
“Nocturnal hypoglycemia in particular may impact one’s sense of well-being on the following day because of its impact on sleep quantity and quality (84).”
BackgroundLy, T. T., Hewitt, J., Davey, R. J., Lim, E. M., Davis, E. A., & Jones, T. W. (2011) · Diabetes Care · doi:10.2337/dc10-1042 · Cited by 81 · cited 1×
“With the low-glucose alarms set at 108 mg/dL, 4 weeks of real-time CGM use restored the epinephrine response and improved adrenergic symptoms during a hyperinsulinemic hypoglycemic clamp in a small group of adolescents with type 1 diabetes and hypoglycemic unawareness (122).”
BackgroundPreventing hypoglycaemia: what is the appropriate glucose alert value?
Cryer, P. E. (2009) · Diabetologia · doi:10.1007/s00125-008-1205-7 · Cited by 77 · cited 3×
“Although this alert value has been debated (9,13,14), a plasma concentration of #70 mg/dL (#3.”
BackgroundSelf-citationBolo, N. R., Musen, G., Jacobson, A. M., Weinger, K., McCartney, R. L., Flores, V., Renshaw, P. F., & Simonson, D. C. (2011) · Diabetes · doi:10.2337/db11-0506 · Cited by 72 · cited 1×
“Despite such reassuring findings, recent investigation with advanced imaging techniques has demonstrated that adults with type 1 diabetes appear to call upon a greater volume of the brain to perform a working memory task during hypoglycemia (45).”
ResultThe impact of aging on adrenergic receptor function: clinical and biochemical aspects
Heinsimer, J. A., & Lefkowitz, R. J. (1985) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1985.tb04890.x · Cited by 67 · cited 1×
“The vulnerability of the elderly to severe hypoglycemia may be partially related to a progressive age-related decrease in -adrenergic receptor function (52).”
BackgroundMeyer, C., Hering, B. J., Gromann, R., Brandhorst, H., Brandhorst, D., Gerich, J., Federlin, K., & Bretzel, R. G. (1998) · Transplantation · doi:10.1097/00007890-199807270-00017 · Cited by 66
Type 1 diabetes and driving experience: an eight-year cohort study
Eadington, D. W., & Frier, B. M. (1989) · Diabetic Medicine · doi:10.1111/j.1464-5491.1989.tb02101.x · Cited by 63
Dose adjustment for normal eating (DAFNE)—an audit of outcomes in Australia
McIntyre, H. D., Knight, B. A., Harvey, D. M., Noud, M. N., Hagger, V. L., & Gilshenan, K. S. (2010) · Medical Journal of Australia · doi:10.5694/j.1326-5377.2010.tb03662.x · Cited by 61 · cited 1×
“These programs have been successfully delivered in other settings (103,104) with comparable reductions in hypoglycemic risk (105).”
BackgroundDelayed Recovery of Cognitive Function Following Hypoglycemia in Adults With Type 1 Diabetes
Zammitt, N. N., Warren, R. E., Deary, I. J., & Frier, B. M. (2008) · Diabetes · doi:10.2337/db07-0695 · Cited by 61 · cited 2×
“On the one hand, patients with hypoglycemia unawareness and type 1 diabetes appear to perform better on tests of cognitive function during hypoglycemia than do patients who are able to detect hypoglycemia normally (37).”
BackgroundMazze, R., Yogev, Y., & Langer, O. (2012) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.3109/14767058.2012.670413 · Cited by 58 · cited 1×
“When pregnant and nonpregnant women are compared with CGM, mild hypoglycemia (defined by the authors as blood glucose ,60 mg/dL) is more common in all pregnant women, but equally so regardless of whether or not they have diabetes, either pregestational or gestational (81).”
BackgroundPaty, B. W., Lanz, K., Kendall, D. M., Sutherland, D. E. R., & Paul Robertson, R. (2001) · Transplantation · doi:10.1097/00007890-200109270-00021 · Cited by 53
Kaufman, F. R., Halvorson, M., & Kaufman, N. D. (1995) · Diabetes Research and Clinical Practice · doi:10.1016/0168-8227(95)01192-7 · Cited by 50
Hypoglycemia preceding fatal car collisions
Cox, D. J., Kovatchev, B., Vandecar, K., Gonder-Frederick, L., Ritterband, L., & Clarke, W. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1836 · Cited by 48
Ritholz, M. D., & Jacobson, A. M. (1998) · Journal of General Internal Medicine · doi:10.1046/j.1525-1497.1998.00243.x · Cited by 44 · cited 1×
“These adults also reported difficulty talking about issues related to hypoglycemia with significant others (87).”
BackgroundPANDYA, N., THOMPSON, S., & SAMBAMOORTHI, U. (2008) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2008.06.003 · Cited by 43 · cited 1×
“Arbitrary short-acting insulin sliding scales, which are used much too often in long-term care facilities (60), should be avoided, and glyburide should be discontinued in favor of shorter-acting insulin secretagogues or medications that do not cause hypoglycemia.”
BackgroundPrevention and Correction of Hypoglycemia: Relevance to Type 1 Diabetes
Cryer, P. E. (2003) · Type 1 Diabetes · doi:10.1007/978-1-59259-310-1_7 · Cited by 42 · cited 1×
“Given the limited accuracy of the monitoring devices, it approximates the lower limit of the normal postabsorptive plasma glucose concentration (15), the glycemic thresholds for activation of glucose counterregulatory systems in nondiabetic individuals (15), and the upper limit of plasma glucose level reported to redu…”
BackgroundSelf-citationHypoglycemia in Type 1 Diabetes Mellitus: Pathophysiology and Prevention
Dagogo-Jack, S. (2004) · Treatments in Endocrinology · doi:10.2165/00024677-200403020-00004 · Cited by 40
Self-citationDurable reversal of hypoglycemia unawareness in type 1 diabetes
Dagogo-Jack, S., Fanelli, C. G., & Cryer, P. E. (1999) · Diabetes Care · doi:10.2337/diacare.22.5.866 · Cited by 35 · cited 2×
“A self-reported history of impaired or absent perception of autonomic symptoms during hypoglycemia correlates strongly with laboratory confirmation of hypoglycemia unawareness (33,121,124,125).”
BackgroundSelf-citation(1993) · PubMed · Cited by 27
Gray, R. O. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.4.1508 · Cited by 26
Should persons with diabetes be licensed to drive trucks?—Risk management
Lave, L. B., Songer, T. J., & LaPorte, R. E. (1993) · Risk Analysis · doi:10.1111/j.1539-6924.1993.tb01084.x · Cited by 23
Reliability of driving performance during moderate hypoglycemia in adults with IDDM
Quillian, W. C., Cox, D. J., Gonder-Frederick, L. A., Driesen, N. R., & Clarke, W. L. (1994) · Diabetes Care · doi:10.2337/diacare.17.11.1367 · Cited by 23
The Prevention and Correction of Hypoglycemia
Cryer, P. E. (2001) · Comprehensive Physiology · doi:10.1002/cphy.cp070235 · Cited by 23
Self-citationBurge, M. R., Sobhy, T. A., Qualls, C. R., & Schade, D. S. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.11.7993 · Cited by 17 · cited 1×
“The intensification of glycemic control in the elderly patient is associated with an increased reduction in the plasma glucose thresholds for epinephrine release and for the appearance of hypoglycemia (56).”
BackgroundGold (1997) · doi:10.1002/(sici)1096-9136(199702)14:2<111::aid-dia309>3.0.co;2-s
Research works printed but not linked: 2
- Reno, 2011, Deaths due to severe hypoglycemia are exacerbated by diabetes and ameliorated by hypoglycemic pre-conditioning (Abstract), Diabetes, 60, A81
- Aubert, 1995, Diabetes-Related Hospitalization and Hospital Utilization
Cited by
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
Marso, S. P., Bain, S. C., Consoli, A., Eliaschewitz, F. G., Jódar, E., Leiter, L. A., Lingvay, I., Rosenstock, J., Seufert, J., Warren, M. L., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1607141 · Cited by 6,900
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“While it was previously thought that young children were at risk for cognitive impairment after episodes of severe hypoglycemia, current data have not confirmed this (295,499,500).”
BackgroundResultBattelino, T., Danne, T., Bergenstal, R. M., Amiel, S. A., Beck, R., Biester, T., Bosi, E., Buckingham, B. A., Cefalu, W. T., Close, K. L., et al. (2019) · Diabetes Care · doi:10.2337/dci19-0028 · Cited by 4,237
Self-citationChatterjee, S., Khunti, K., & Davies, M. J. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30058-2 · Cited by 2,577
DiMeglio, L. A., Evans-Molina, C., & Oram, R. A. (2018) · The Lancet · doi:10.1016/s0140-6736(18)31320-5 · Cited by 1,561
Metadata
- Authors
- Seaquist, E. R., Anderson, J., Childs, B., Cryer, P., Dagogo-Jack, S., Fish, L., Heller, S. R., Rodriguez, H., Rosenzweig, J., & Vigersky, R.
- Affiliations
- University of Minnesota (US)
- The Frist Clinic, Nashville, Tennessee;
- Mid-America Diabetes Associates, Wichita, Kansas; the
- Washington University in St. Louis (US)
- University of Tennessee Health Science Center (US)
- Park Nicollet Clinic (US)
- University of Sheffield (GB)
- University of South Florida (US)
- Boston University (US)
- Walter Reed National Military Medical Center (US)
- Corresponding author
- Seaquist, Elizabeth R.
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2013-04-13
- Volume
- 36
- Issue
- 5
- Pages
- 1384-1395
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3631867
- OpenAlex
- W2109416725
- Cited by
- 1,389
- References
- 141
- Citations by year
- 2026: 43 · 2025: 47 · 2024: 62 · 2023: 66 · 2022: 92 · 2021: 127 · 2020: 119 · 2019: 149 · 2018: 148 · 2017: 151 · 2016: 129 · 2015: 129 · 2014: 92 · 2013: 33
- FWCI
- 100.42
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- Eli Lilly and Company
- Sanofi
- National Institute for Health and Care Research (NF-SI-0611-10248)
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Patient Safety and Medication Errors
- Keywords
- hypoglycemia, diabetes mellitus, hypoglycemia definition, hypoglycemia prevention, long-term outcomes, patient counseling, clinical guidelines
- MeSH terms
- Diabetes Mellitus, Humans, Hypoglycemia, Societies, Medical, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.